-
Mashup Score: 0FDA Approves First Gene Therapy for Duchenne Muscular Dystrophy - 8 month(s) ago
The US FDA has approved the gene therapy, delandistrogene moxeparvovec (Elevidys), to treat patients ages 4 through 5 years with Duchenne muscular dystrophy.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
How much do you know about the current approaches to diagnosing and treating Duchenne muscular dystrophy (DMD)?
Source: www.medscape.orgCategories: Latest Headlines, NeurologyTweet-
📝 How much do you know about the current approaches to diagnosing and treating Duchenne muscular dystrophy? #DMD #MedEd #CME #NeuroX ➡️ https://t.co/cg2rGpVUHN https://t.co/h7X5vilnLe
-
-
Mashup Score: 1
How much do you know about the current approaches to diagnosing and treating Duchenne muscular dystrophy (DMD)?
Source: www.medscape.orgCategories: Latest Headlines, NeurologyTweet-
📝 How much do you know about the current approaches to diagnosing and treating Duchenne muscular dystrophy? #DMD #MedEd #CME #NeuroX ➡️ https://t.co/Gu9pPvRgOS https://t.co/7pgyzSXlSB
-
-
Mashup Score: 3
How much do you know about the current approaches to diagnosing and treating Duchenne muscular dystrophy (DMD)?
Source: www.medscape.orgCategories: Latest Headlines, NeurologyTweet-
📝 How much do you know about the current approaches to diagnosing and treating Duchenne muscular dystrophy? #DMD #MedEd #CME #NeuroX ➡️ https://t.co/JDC5XClBKl https://t.co/jU69dKqRWr
-
-
Mashup Score: 1
How much do you know about the current approaches to diagnosing and treating Duchenne muscular dystrophy (DMD)?
Source: www.medscape.orgCategories: Latest Headlines, NeurologyTweet-
📝 How much do you know about the current approaches to diagnosing and treating Duchenne muscular dystrophy? #DMD #MedEd #CME #NeuroTwitter ➡️ https://t.co/57LjcjEz15 https://t.co/oAcP1HebNB
-
-
Mashup Score: 1FDA Approves First Gene Therapy for Duchenne Muscular Dystrophy - 9 month(s) ago
The US FDA has approved the gene therapy, delandistrogene moxeparvovec (Elevidys), to treat patients ages 4 through 5 years with Duchenne muscular dystrophy.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The US Food and Drug Administration #FDA has approved the gene therapy, delandistrogene moxeparvovec (Elevidys), to treat patients ages 4 through 5 years with Duchenne muscular dystrophy #DMD #checkrare @CureDuchenne @DuchenneUK https://t.co/44r3YdJChW
-
-
Mashup Score: 0FDA Approves First Gene Therapy for Duchenne Muscular Dystrophy - 10 month(s) ago
The US FDA has approved the gene therapy, delandistrogene moxeparvovec (Elevidys), to treat patients ages 4 through 5 years with Duchenne muscular dystrophy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The US Food and Drug Administration #FDA has approved the gene therapy, delandistrogene moxeparvovec (Elevidys), to treat patients ages 4 through 5 years with Duchenne muscular dystrophy #DMD #checkrare @CureDuchenne @DuchenneUK https://t.co/44r3YdJChW
-
-
Mashup Score: 0FDA Approves First Gene Therapy for Duchenne Muscular Dystrophy - 10 month(s) ago
The US FDA has approved the gene therapy, delandistrogene moxeparvovec (Elevidys), to treat patients ages 4 through 5 years with Duchenne muscular dystrophy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The US Food and Drug Administration #FDA has approved the gene therapy, delandistrogene moxeparvovec (Elevidys), to treat patients ages 4 through 5 years with Duchenne muscular dystrophy #DMD #checkrare @CureDuchenne @DuchenneUK https://t.co/44r3YdJChW
-
-
Mashup Score: 0
How much do you know about the current approaches to diagnosing and treating Duchenne muscular dystrophy (DMD)?
Source: MedscapeCategories: Latest Headlines, PediatricsTweet-
📝 How much do you know about the current approaches to diagnosing and treating Duchenne muscular dystrophy? #DMD #pediatrician #CME #MedTwitter ➡️ https://t.co/eZWeCDqbqa https://t.co/XuPt242exD
-
-
Mashup Score: 0
How much do you know about the current approaches to diagnosing and treating Duchenne muscular dystrophy (DMD)?
Source: MedscapeCategories: Latest Headlines, PediatricsTweet-
📝 How much do you know about the current approaches to diagnosing and treating Duchenne muscular dystrophy? #DMD #pediatrician #CME #MedTwitter ➡️ https://t.co/2GgsnMggjH https://t.co/VZlZlTJu1O
-
The US Food and Drug Administration #FDA has approved the gene therapy, delandistrogene moxeparvovec (Elevidys), to treat patients ages 4 through 5 years with Duchenne muscular dystrophy #DMD #checkrare @CureDuchenne @DuchenneUK https://t.co/44r3YdJChW